Home » HIKMA PHARMACEUTICALS SAYS PLANS LONDON IPO
HIKMA PHARMACEUTICALS SAYS PLANS LONDON IPO
November 1, 2005
Generic drug company Hikma Pharmaceuticals said on Monday it planned to float
on the London Stock Exchange with a price range of 265 to 330 pence, the middle
of which values it at about 500 million pounds ($874.9 million).